瓶型酵母D | 72877-47-5

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 核苷和核苷酸类似物
• 中文名称: 瓶型酵母D
• 英文名称: heplanocin D
• 英文别名: neplanocin A；(1'R,2'S,3'R)-9-[2,3-dihydroxy-4-hydroxymethyl-4-cyclopenten-1-yl]hypoxanthine；Neplanocin D；9-[(1R,4R,5S)-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl]-1H-purin-6-one
• CAS: 72877-47-5
• 化学式: C₁₁H₁₂N₄O₄
• 分子量: 264.241
• InChiKey: ZOGIBYIZRGKFQR-VDAHYXPESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.2
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  120
• 氢给体数：
  4
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  瓶型酵母D 在 吡啶 、 氯化亚砜 、 对甲苯磺酸 作用下， 以 氯仿 、 N,N-二甲基甲酰胺 为溶剂， 反应 8.0h， 生成 6-chloro-9-<(1R,2S,3R)-4-(hydroxymethyl)-2,3-(isopropylidenedioxy)-4-cyclopenten-1-yl>purine
  参考文献：
  名称：

  新的内啡肽类似物。1.合成6'-修饰的neplanocin A衍生物作为广谱抗病毒剂。

  摘要：

  在6'-位修饰的新型neplanocin A类似物，即6'-deoxy类似物（2、3、6、9、20），6'-O-甲基内啡肽A（15）和6'-C-甲基内啡肽A （22a和22b）（22a和22b）已被合成并评估了其在各种DNA和RNA病毒系统中的抗病毒活性。这些化合物显示出与S-腺苷同型半胱氨酸水解酶抑制剂相符的活性谱。它们对痘病毒（牛痘），副粘病毒（副流感，麻疹，呼吸道合胞），竞技场（朱宁，塔卡里布），弹状病毒（水疱性口腔炎），呼肠孤病毒和巨细胞病毒特别有效。按照（增加）抗病毒活性的顺序，化合物的等级如下：3小于15约20小于6小于9约22小于22a。在22的两种非对映异构形式中，只有22a是活跃的。22a在抗病毒效力和选择性方面均超过neplanocinA。化合物22a似乎是治疗pox病毒，副粘病毒病毒，arena病毒，rhabdo病毒，reo病毒和巨细胞病毒感染的有前途的候选药物。

  DOI：

  10.1021/jm00080a018
• 作为产物：
  描述：

  (+/-)-2,2-dimethyl-3αβ,6αβ-dihydro-4H-cyclopenta-1,3-dioxol-4-one 在 4-二甲氨基吡啶 、 双(乙腈)氯化钯(II) 、 potassium tert-butylate 、 仲丁基锂 、 sodium methylate 、 potassium carbonate 、 三乙胺 、 三苯基膦 、 三氟乙酸 、 2-巯基乙醇 、 对苯醌 、 偶氮二甲酸二乙酯 作用下， 以 四氢呋喃 、 甲醇 、 正己烷 、 二氯甲烷 为溶剂， 反应 100.5h， 生成 瓶型酵母D
  参考文献：
  名称：

  Enantiomeric Synthesis of d- and l-Cyclopentenyl Nucleosides and Their Antiviral Activity Against HIV and West Nile Virus

  摘要：

  Enantiomeric synthesis Of D- and L-cyclopentenyl nucleosides and their antiviral activity against HIV and West Nile virus are described. The key intermediate (-)- and (+)-cyclopentenyl alcohols (7 and 15) were prepared from D-gamma -ribonolactone and D-ribose, respectively. Coupling of 7 with appropriately blocked purine and pyrimidine bases via the Mitsunobu reaction followed by deprotection afforded the target L-(+)-cyclopentenyl nucleosides (24-28, 31, 33, and 36). D-(-)Cyclopentenyl nucleosides (1, 40, 43, and 52-56) were also prepared by a similar procedure for L-isomers from 15. The synthesized compounds were evaluated for their antiviral activity against two RNA viruses: HIV and West Nile virus. Among the synthesized D-(-)-nucleosides, adenine (1, neplanocin A), cytosine (55, CPE-C), and 5-fluorocytosine (56) analogues exhibited moderate to potent anti-HIV activity (EC50 0.1, 0.06, and 5.34 muM, respectively) with significant cytotoxicity in PBM, Vero, and CEM cells. Also, cytosine (55) and 5-fluorocytosine (56) analogues exhibited the most potent anti-West Nile virus activity (EC50 0.2-3.0 and 15-20 muM, respectively). Among L-(+)-nucleosides, only the cytosine (27) analogue exhibited weak anti-HIV activity (EC50 58.9 muM).

  DOI：

  10.1021/jm010256v

文献信息

• [EN] 3-DEAZANEPLANOCIN DERIVATIVES<br/>[FR] DÉRIVÉS 3-DÉSAZANÉPLANOCINE
  申请人：AGENCY SCIENCE TECH & RES

  公开号：WO2010036213A1

  公开（公告）日：2010-04-01

  This invention describes the series of compounds based on the 3-deazaneplanocin A (DZNep) core structure designed to inhibit the function of Polycomb repressive complex 2 (PRC2) proteins.

  这项发明描述了基于3-去氮烯普拉辛A（DZNep）核心结构的一系列化合物，旨在抑制Polycomb抑制性复合物2（PRC2）蛋白的功能。
• 3-Deazaneplanocin Derivatives
  申请人：Chai Christina L. L.

  公开号：US20110237606A1

  公开（公告）日：2011-09-29

  This invention describes the series of compounds based on the 3-deazaneplanocin A (DZNep) core structure designed to inhibit the function of Polycomb repressive complex 2 (PRC2) proteins.

  这项发明描述了基于3-去氮依普利新A（DZNep）核心结构的一系列化合物，旨在抑制多能性组蛋白抑制复合物2（PRC2）蛋白的功能。
• Enantiomeric Synthesis of <scp>d</scp>- and <scp>l</scp>-Cyclopentenyl Nucleosides and Their Antiviral Activity Against HIV and West Nile Virus
  作者：Gyu Y. Song、Vincent Paul、Hyunah Choo、John Morrey、Robert W. Sidwell、Raymond F. Schinazi、Chung K. Chu

  DOI：10.1021/jm010256v

  日期：2001.11.1

  Enantiomeric synthesis Of D- and L-cyclopentenyl nucleosides and their antiviral activity against HIV and West Nile virus are described. The key intermediate (-)- and (+)-cyclopentenyl alcohols (7 and 15) were prepared from D-gamma -ribonolactone and D-ribose, respectively. Coupling of 7 with appropriately blocked purine and pyrimidine bases via the Mitsunobu reaction followed by deprotection afforded the target L-(+)-cyclopentenyl nucleosides (24-28, 31, 33, and 36). D-(-)Cyclopentenyl nucleosides (1, 40, 43, and 52-56) were also prepared by a similar procedure for L-isomers from 15. The synthesized compounds were evaluated for their antiviral activity against two RNA viruses: HIV and West Nile virus. Among the synthesized D-(-)-nucleosides, adenine (1, neplanocin A), cytosine (55, CPE-C), and 5-fluorocytosine (56) analogues exhibited moderate to potent anti-HIV activity (EC50 0.1, 0.06, and 5.34 muM, respectively) with significant cytotoxicity in PBM, Vero, and CEM cells. Also, cytosine (55) and 5-fluorocytosine (56) analogues exhibited the most potent anti-West Nile virus activity (EC50 0.2-3.0 and 15-20 muM, respectively). Among L-(+)-nucleosides, only the cytosine (27) analogue exhibited weak anti-HIV activity (EC50 58.9 muM).
• New neplanocin analogs. 1. Synthesis of 6'-modified neplanocin A derivatives as broad-spectrum antiviral agents
  作者：Satoshi Shuto、Takumi Obara、Minoru Toriya、Mitsuaki Hosoya、Robert Snoeck、Graciela Andrei、Jan Balzarini、Erik De Clercq

  DOI：10.1021/jm00080a018

  日期：1992.1

  Novel neplanocin A analogues modified at the 6'-position, i.e., 6'-deoxy analogues (2, 3, 6, 9, 20), 6'-O-methylneplanocin A (15), and 6'-C-methylneplanocin A's (22a and 22b) have been synthesized and evaluated for their antiviral activity in a wide variety of DNA and RNA virus systems. These compounds showed an activity spectrum that conforms to that of S-adenosylhomocysteine hydrolase inhibitors

  在6'-位修饰的新型neplanocin A类似物，即6'-deoxy类似物（2、3、6、9、20），6'-O-甲基内啡肽A（15）和6'-C-甲基内啡肽A （22a和22b）（22a和22b）已被合成并评估了其在各种DNA和RNA病毒系统中的抗病毒活性。这些化合物显示出与S-腺苷同型半胱氨酸水解酶抑制剂相符的活性谱。它们对痘病毒（牛痘），副粘病毒（副流感，麻疹，呼吸道合胞），竞技场（朱宁，塔卡里布），弹状病毒（水疱性口腔炎），呼肠孤病毒和巨细胞病毒特别有效。按照（增加）抗病毒活性的顺序，化合物的等级如下：3小于15约20小于6小于9约22小于22a。在22的两种非对映异构形式中，只有22a是活跃的。22a在抗病毒效力和选择性方面均超过neplanocinA。化合物22a似乎是治疗pox病毒，副粘病毒病毒，arena病毒，rhabdo病毒，reo病毒和巨细胞病毒感染的有前途的候选药物。